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A 29-year-old female presented with gradually developing,Figure 2:generalized vague abdominal pain since 3 months. There were
no associated constitutional symptoms. Her abdominal exam-
ination revealed a ﬁrm, well-circumscribed, non-tender and
mobile mass ﬁlling all quadrants of the abdomen. The initial
laboratory work-up was normal while the images of the con-
trast-enhanced CT scan are illustrated in Fig. 1. The patient
underwent exploratory laparotomy and a mass was removed.
The ﬁnal histological picture of the mass is shown in Fig. 1.
What is the most probable diagnosis?Figure 1:
Figure 4:
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S.Y. Guraya 119There are diverse causes of vague abdominal pain including
inﬂammatory, neoplastic, traumatic, and obstructive factors.
Out of the neoplastic etiologies, the benign tumors often pose
diagnostic challenges to the treating physicians. Mesenteric
ﬁbromatosis is one of the uncommon clinical entities which
is rarely reported in the literature with a wide range of presen-
tations including pain and discomfort, constipation, vomiting,
weight loss and organ compression symptoms, such as small
bowel obstruction and hydronephrosis.1 Various etiopathoge-
netic theories have been coined but the exact nature of the
causative agent still remains unknown. Trauma2, infectious eti-
logy due to its association with retroperitoneal ﬁbromatosis3,
and genetic predisposition may play a role in the development
of this disease. The differential diagnosis often includes gastro-
intestinal stromal tumors and less commonly ﬁbrosarcomas or
inﬂammatory ﬁbroid polyps.4
The microscopic examination of mesenteric ﬁbromatosis
shows minimally positive desmin, vimentin positive, S100 min-
imally focally positive, cd34 negative, SMA focally positive
and MSA largely negative, and Cd117 positive. All these
tumor markers are pathognomic of mesenteric ﬁbromatosis.5
The mitotic count is relatively low with no evidence of necrosis
and nuclear dedifferentiation. On CT scan, ﬁbromatosis may
present as a solitary or multiple, well-deﬁned or ill-deﬁned
mass with attenuation similar to muscles. A whorled appear-
ance, with radiating mesenteric strands, displacement, retrac-
tion and/or compression of the bowel loops, has also been
described.6 Surgical excision by taking wide margins of the
normal surrounding tissue remains the mainstay of treatment.
Large tumor size (larger than 10 cm), multiplicity, extensive tu-
mor invasion, encasement of small bowel loops and entrap-
ment of the ureter have been reported as poor prognostic
factors in familial adenomatous polyposis patients with mesen-teric ﬁbromatosis.7 For extensive inﬁltrative tumors, various
nonsurgical treatments have been tried; estrogen receptor
antagonist, tamoxifen; nonsteroidal antiinﬂammatory agents;
aromatase inhibitor therapy; chemotherapy with dactinomy-
cin, vincristine, and cyclophosphamide; and radiotherapy, sin-
gly or in combination.8
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